Harvoni - Hepatitis C
You are here : Home > Formulary Search > Harvoni - Hepatitis C
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Harvoni
Indication :
Hepatitis C
Group Name :
Keywords :
Hep C, NICE, cirrhosis, child-pugh class A, HCV, hepatitis c virus, chronic, genotype
Brand Names Include :
Ledipasvir 90mg/sofosbuvir 400mg
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Committee Recommendations (1)
Implementation of NICE TA 363 - Ledipasvir-sofosbuvir is recommended by NICE guidance. Funding responsibility rests with NHS England, treatment should remain with the specialist in secondary care.
Other Indications
Below are listed other indications that Harvoni is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hepatitis C.
- Asunaprevir and daclatasvir
- Beclabuvir
- Daclatasvir
- Dasabuvir
- Elbasvir
- Elbasvir/grazoprevir
- Filibuvir
- Glecaprevir/pibrentasvir
- Ledipasvir/sofosbuvir
- Nitazoxanide
- Paritaprevir
- Peginterferon alfa
- Ribavirin
- Setrobuvir
- Sofosbuvir
- Sofosbuvir and velpatasvir
- Sofosbuvir with daclatasvir and ribavirin
- Sofosbuvir/velpatasvir/voxilaprevir
- Zepatier